Sponsor Dossier
Waymade
Sponsor Dossier for Waymade. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ARX-LEVOTHYROXINE
- Brand: ARX-TRANEXAMIC
- Brand: MARAVIROC WAYMADE
- Brand: NEUPEDIX
- Brand: RISEDRONATE
- Brand: SEVELAMER
- Brand: THYROX
- Brand: TRANEXAMIC
About
Waymade is an Australian Private Company with ABN 85 635 010 598, registered in NSW. The company is active and GST-registered.
Portfolio
Waymade has 9 brands on the ARTG, of which 7 are indexable and 7 carry a Product Information document. 5 brands are PBS-listed, 1 has a PBAC outcome on record, and 1 has an AusPAR on record. Notable brands include ARX-LEVOTHYROXINE, ARX-TRANEXAMIC, MARAVIROC WAYMADE, NEUPEDIX, RISEDRONATE, SEVELAMER, THYROX, TRANEXAMIC, TRIENTINE.
Therapeutic focus
— Endocrinology: 2 brands — Haematology: 2 brands — Rare Disease: 1 brand — Infectious Disease: 1 brand — Musculoskeletal: 1 brand — Renal: 1 brand — Cardiology: 1 brand
PBS footprint
5 brands are PBS-listed, with the latest PBS schedule date 2026-10-01.
Regulatory activity
The latest PBAC outcome is 2019-03-01, across 1 brand with a PBAC outcome on record. The latest AusPAR is 2021-05-03, across 1 brand with an AusPAR on record.